1,347
Views
24
CrossRef citations to date
0
Altmetric
Adherence

Is the MARS questionnaire a reliable measure of medication adherence in childhood asthma?

, MD, , MD, PhD, , PhD & , MD, PhD
Pages 1085-1089 | Received 01 Feb 2016, Accepted 17 Apr 2016, Published online: 03 Aug 2016
 

Abstract

Objective: To assess the reliability of the Medication Adherence Report Scale (MARS-5) for assessing adherence in clinical practice and research. Methods: Prospective cohort study following electronically measured inhaled corticosteroids (ICS) adherence for 1 year in 2–13-year-old children with persistent asthma. The relationship between electronically measured adherence and MARS-5 scores (ranging from 5 to 25) was assessed by Spearman's rank correlation coefficient. A ROC (receiver operating characteristic) curve was performed testing MARS-5 against electronically measured adherence. Sensitivity, specificity, positive and negative likelihood ratios of the closest MARS-5 cut-off values to the top left-hand corner of the ROC curve were calculated. Results: High MARS scores were obtained (median 24, interquartile range 22–24). Despite a statistically significant correlation between MARS-5 and electronically assessed adherence (Spearman's rho = 0.47; p < 0.0001), there was considerable variation of adherence rates at every MARS-5 score. The area under the ROC curve was 0.7188. A MARS-5 score ≥23 had the best predictive ability for electronically assessed adherence, but positive and negative likelihood ratios were too small to be useful (1.65 and 0.27, respectively). Conclusions: Self-report using MARS-5 is too inaccurate to be a useful measure of adherence in children with asthma, both in clinical practice and in research.

Declaration of interest

The study sponsors had no role in study design, the collection, analysis and interpretation of data, the writing of the report, and the decision to submit the manuscript. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.

Funding

This study was supported by a grant from the Netherlands Asthma Foundation (grant no 3.4.06.007) and from the Foundation to Combat Asthma (Stichting Astmabestrijding).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.